What's Good for the Generics... The AP reports in "Drug Patents Don't Bar Rival Research - Yahoo! News." : "It means that big drug companies will have more flexibility to start experimenting with potential therapies so long as they cannot feasibly be marketed until after a competitor's patent expires. Lower courts will have to sort out just how much leeway the companies will have."